Charles River Laboratories International, Inc. closed at $272.90 on September 16, 2026, edging down 0.03% in the latest 24-hour session. The marginal daily decline kept the stock within a broader downward trend that has persisted over recent weeks.
Over the past seven days, CRL has lost 2.80%, and the 30-day decline now stands at 4.59%. The cumulative pressure over that period reflects sustained selling interest in the shares, though the daily moves have remained relatively contained.
The company carries a market capitalization of $13.04 billion, maintaining its position as one of the larger players in the contract research and laboratory services space. Wednesday's session did not produce any dramatic swings, with the stock's fractional move suggesting measured trading activity.
CRL's price action over the past month points to a gradual erosion of value rather than any single sharp correction. The 30-day loss of 4.59% combined with the seven-day decline of 2.80% indicates the pace of selling has been relatively steady across the period.
